The Impact of Changed Strategies for Patients with Cholangiocarcinoma in This Millenium

Table 2

(a) Clinical staging and Bismuth staging of 163 patients with perihilar cholangiocarcinoma (PHC) in the three time periods. (b) Therapy for 163 patients with perihilar cholangiocarcinoma (PHC) in the three time periods.

(a)

Staging/year	2000–2003	2004–2007	2008–2011	Total
T0	3	0	0	3
T1	2	5	2	9
T2	3	5	9	17
T3	1	3	5	9
T4	1	1	3	5
N1	9	11	10	30
M+	17	16	20	53
Not staged	13	12	12	37
Total	49	53	61	163
Bismuth staging
1	13	8	11	32
2	1	0	6	7
3	5	6	14	25
4	5	5	21	31
Not staged	25	34	9	68

(b)

Treatment/year	2000–2003	2004–2007	2008–2011	Total
Curative aim
Liver resection; + bile duct resection	5	11	9	25
Bile duct resection	6	1	3	10
Transplantation	2	0	4	6
Active palliative
Chemotherapy	2	9	12	23
Miscellaneous	8	3	0	11
BSC	26	29	33	82
Total	49	53	61	163